Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance.
At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply directly via LinkedIn or our website. We do not post job openings at other sites.
Company Details
- Employees
- 26
- Founded
- 2018
- Address
- Durham Fwy, Durham,north Carolina,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Drug Discovery and AI.
- HQ
- Durham, North Carolina
Ten63 Therapeutics Questions
Ten63 Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ten63tx
Ten63 Therapeutics has
26 employees.
View email and phone details for 26
employees at Ten63 Therapeutics.
Ten63 Therapeutics's industry is
Biotechnology Research
Ten63 Therapeutics's top competitors are
Tune Therapeutics,
Terray Therapeutics,
Ribometrix Inc.,
Nivien Therapeutics,
Atsena Therapeutics,
Fekra Therapeutics,
Cape Fear Biocapital,
Tavros Therapeutics,
Biolabs North Carolina,
Vividion Therapeutics, Inc..
Ten63 Therapeutics's categories are Biotechnology Research
Ten63 Therapeutics's founding year is 2018
